Renal transplantation offers improved survival and quality of life compared to staying on dialysis.
from apoptotic and necrotic cells led to dramatically higher serum HMGB1 levels and increased proinflammatory macrophages in recipients of KIM-1 −/− grafts. Our data identify an endogenous protective mechanism against necroinflammation in kidney grafts that may be of therapeutic relevance in transplantation.
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Although kidneys have tremendous capacity for repair, severe injury and/or unregulated inflammation can hinder this ability. 6 The passive release of danger-associated molecular patterns released into circulation from many types of allografts after transplantation and inhibiting its function has been shown to dampen alloresponses and even prolong graft survival in several preclinical models.
12-14
Kidney injury molecule-1 (KIM-1, also known as TIM- 1 15 ) is a type 1 transmembrane glycoprotein that is upregulated on renal PTECs following injury. 16 We and others have previously reported that KIM-1 is a phosphatidylserine (PS) receptor expressed on PTECs, transforming them into semiprofessional phagocytes for neighboring apoptotic and necrotic cells. [17] [18] [19] It is important to note that primary PTECs are entirely dependent on KIM-1 for efferocytosis. 
| Renal transplantation
Male KIM-1 +/+ C57BL/6 recipient mice were bilaterally (sequentially)
nephrectomized and transplanted with a single donor kidney from 
| In vivo HMGB1
Posttransplantation serum was collected and serum HMGB1 was quantitatively determined using Sandwich-enzyme immunoassay kit in accordance with its protocol (Shino-Test Corporation, Tokyo, Japan). Multiskan GO software was used for quantification (Thermo Fisher Scientific, Rockford, IL).
| Phagocytosis assay/in vitro HMGB1
Thymocytes were isolated from C57BL/6 mice at 3-to 6-weeks-old.
To induce apoptotic cells, thymocytes were placed under UV light for 5 minutes followed by overnight incubation at 37°C in 5% (vol/ 
| Western blot
Tissue sections were stored in 4% Sodium dodecyl sulphate (SDS).
Pierce BCA Protein Assay Kit (Thermo Fisher Scientific, Rockford, IL) was used to quantify isolated proteins from whole tissue sections. We incubated the blots with mouse polyclonal KIM-1 (R&D Systems Inc., Minneapolis, MN) and mouse monoclonal GAPDH antibody (Santa Cruz Biotechnology, Santa Cruz, CA). Western blots were developed and quantified using the FluorChem M system (ProteinSimple, San Jose, CA).
| RNA isolation and polymerase chain reaction
Tissue sections were collected in TriPure isolation reagent (Roche Diagnostic, Basel, Switzerland) and total RNA was extracted. 
| Histology, immunohistochemistry
Tissue sections were stored in 10% formalin before sectioning. A renal pathologist, blinded to the groups, scored the tissue sections that were stained with hematoxylin and eosin (H&E) using a previ- 
| Immunofluorescence
Ethidium homodimer (EHD; Invitrogen, Carlsbad, CA) was used to quantify necrosis in kidney graft sections. 5 μM EHD was injected into the renal artery for 10 minutes at a speed of 1 mL/min, followed by another 10 minutes of PBS at the same speed.
14 Frozen sections were used and areas of necrosis were quantified using a FLUOVIEW X831 confocal microscopy (Olympus, Tokyo, Japan). A total of 5 random nonoverlapping sections of the outer cortex were taken per slide. Quantification was done using ImageJ software (National Institutes of Health, Bethesda, MD).
| Statistical analysis
Log-rank test was used to determine the graft survival. One-way analysis of variance (ANOVA) was used for multiple comparisons, whereas t-test was used for unpaired values. Mann-Whitney test was used when comparing nonparametric data. All these tests were carried out using GraphPad Prism software (GraphPad Software Inc., La Jolla, CA). All data are presented as means ± standard error of the mean (SEM), and P < .05 was used for significance.
| RE SULTS AND D ISCUSS I ON
We characterized the expression of KIM-1 following transplantation. Graft KIM-1 expression was persistently upregulated even grafts also exhibited significantly reduced 7-day survival compared to mice receiving wild-type grafts (5/5 vs 3/12, P = .0105; Figure 1D ).
Given the essential role of KIM-1 in the phagocytic clearance of apoptotic 27 and necrotic cells in the kidney, 19 we expected that the poor transplant outcomes associated with donor KIM-1 deficiency would be associated with increased tubular cell apoptosis and necrosis (secondary necrosis of uncleared apoptotic cells 27 ) early after transplantation. Mice transplanted with KIM-1-deficient donor kidneys exhibited increased numbers of both apoptotic (16.67 ± 3.333 vs 3.75 ± 2.394, P = .0018; Figure 2A ) and necrotic cells (11.5 ± 1.041 vs 0.5333 ± 0.1202, P = .0005; Figure 2B ) compared to mice transplanted with wild-type donor kidneys. In addition, we looked at ATN to determine the degree of graft injury. As shown in Figure 2C , KIM-1-deficient donor grafts revealed significantly greater ATN scores compared to the wild-type grafts on day 3 posttransplantation (4 vs 0.5, P = .0286; Figure 2C ). We also observed persistent tubular obstruction, which contributes to kidney dysfunction, 11 more so in the KIM-1 −/− grafts compared to the KIM-1 +/+ grafts (3.5 vs 0.5, P = .0286; Figure 2D ). A lack of any difference at day 1 here is likely explained by the fact that KIM-1 does not affect PTEC death due to cIRI, 20, 21 but rather the removal of debris after acute injury.
An important, yet unanswered, question is whether endogenous clearance of apoptotic and necrotic cells, and reduction in the burden of secondary necrotic or necrotic cells, 28 would lead to a decreased release of DAMPs 27 and tissue inflammation. Furthermore, although mice carrying global defects in efferocytosis pathways are known to exhibit systemic autoimmunity, 29, 30 systemic inflammation has not been attributed to such defects during acute tissue injury. When we analyzed the grafts for markers of inflammation, we noted that the absence of KIM-1 exacerbated the intragraft inflammatory response. There was significantly more granulocyte infiltration at both days 3 (1.2 ± 0.7348 vs 0 ± 0, P = .0060) and 7 (2.333 ± 2.333 vs 0 ± 0, P = .0156; Figure 3A ).
Similarly, there was significantly higher macrophage infiltration at day 7 posttransplantation (10 ± 1.225 vs 4.75 ± 0.4787, P = .0072; Figure 3B ) in KIM-1 −/− vs wild-type grafts. In parallel, KIM-1 −/− grafts also exhibited significantly greater expression of IL-6 (45.08 ± 13.07 vs 11.32 ± 0.8026, P = .0419) and MIP-2α (108.6 ± 22.5 vs 29.48 ± 13.22, P = .0231; Figure 3C ) compared to mice transplanted with wild-type grafts at day 3 following transplantation.
To formally test if the inability of PTECs to clear dying cells would
lead to increased passive release of HMGB1, we conducted an in vitro study where either healthy, apoptotic (UV light-induced) 31 or necrotic (heat-killed) 19 cells were fed to primary PTECs isolated from the kidneys of either KIM-1 −/− or KIM-1 +/+ mice, as shown previously, 20 and analyzed the conditioned media for HMGB1 after 24 hours ( Figure 4A ). Virtually none to very little HMGB1 was detected by Western blot when healthy cells were fed to PTECs. In contrast, the conditioned medium from KIM-1 −/− PTECs fed with apoptotic cells (that underwent secondary necrosis after 24 hours) had a significantly higher relative ratio level of HMGB1 compared to wild-type PTECs (3.568 ± 0.7507 vs 1 ± 0, P = .0268; Figure 4B ).
As expected, when necrotic cells were fed to PTECs of either genotype, no significant difference in the level of HMGB1 was detected, since we previously showed that AIM (opsonin) is required for KIM-1-mediated clearance of necrotic cells. Figure 4D ) following transplantation.
F I G U R E 4
Absence of KIM-1 in the donor kidney leads to increased release of HMGB1. (A-B) PTECs isolated from either KIM-1 deficient or WT mice were fed either thymocytes that were healthy, apoptotic, or necrotic. After 24 hours, conditioned media was collected and HMGB1 release was measured. (A) HMGB1 release was confirmed in the conditioned media using western blots. (B) Relative quantification of western blots (*P < .05, n = 3). (C) In vivo serum HMGB1 was quantified using an ELISA kit at days 1, 3, and 7 posttransplantation (*P < .05, **P < .01, n = 3-4). (D) M1:M2 macrophage ratio using markers CD80 and CD206 respectively, on days 1, 3, and 7 posttransplantation (*P < .05, ** P < .001, n = 3)
Renal replacement therapy is absolutely needed for patients with end-stage renal disease, and renal transplantation is considered the best treatment. 1 However, the lifespan of the kidney grafts is limited as they are subjected to persistent inflammation and fibrosis due to repeated injury. 1 Graft inflammation can impair the induction of transplant tolerance and enhance acute and chronic rejection. 12 Emerging data suggest that necroinflammation triggered by cIRI may sustain graft inflammation via activation of innate and adaptive (and alloimmune) immune pathways. 33, 34 DAMPs, specifically HMGB1, have been shown to be a key mediator of this process. 9, 14, 35 HMGB1, an endogenous nuclear factor normally contained within the nucleus but released when a cell undergoes necrosis or secondary necrosis, has been implicated in the pathogenesis of IRI by stimulating TLR4 signaling. Through TLR4 signaling, HMGB1 has been reported to have a proinflammatory role during IRI, leading to organ damage including the kidneys.
9
Kidney injury molecule-1 (KIM-1) is a type 1 transmembrane glycoprotein that is specifically upregulated on the apical membrane of renal PTECs following AKI. 16 Given our previous work demonstrated that KIM-1 upregulation on PTECs is required for clearing apoptotic or necrotic cells during acute injury, 18, 19 this study has uncovered a fundamental role for donor KIM-1-mediated efferocytosis in inhibiting local and systemic necroinflammation.
In summary, we were the first to elucidate the protective role of donor KIM-1 in mitigating tissue damage and cell death in postrenal transplant in a life-saving syngeneic murine model. Because delayed graft function is a risk factor for rejection and poor long-term graft survival, 3, 36 we provide the first evidence to support the use of therapeutic strategies to enhance the clearance of apoptotic and necrotic cells, 18 or HMGB1 signaling, 35 during renal transplantation to improve overall graft survival.
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